AAV-PHP.eB-Medium OSK Expression Reverses Cortical Neuronal Epigenetic Age Without Altering Glial Transcriptome

Target: OCT4/SOX2/KLF4 (OSK)/Epigenetic clock Composite Score: 0.520 Price: $0.52 Citation Quality: Pending neurodegeneration Status: proposed

☰ Compare ⚔ Duel ⚛ Collideinteract with this hypothesis

✓ All Quality Gates Passed

Quality Report Card click to collapse

C+

Composite: 0.520

Top 75% of 1166 hypotheses

T4 Speculative

Novel AI-generated, no external validation

Needs 1+ supporting citation to reach Provisional

C Mech. Plausibility 15% 0.45 Top 86%

C+ Evidence Strength 15% 0.58 Top 54%

B+ Novelty 12% 0.78 Top 37%

D Feasibility 12% 0.35 Top 86%

B Impact 12% 0.65 Top 57%

C Druggability 10% 0.40 Top 78%

D Safety Profile 8% 0.38 Top 88%

B Competition 6% 0.62 Top 63%

C+ Data Availability 5% 0.52 Top 66%

C Reproducibility 5% 0.48 Top 78%

Evidence

2 supporting | 3 opposing

Citation quality: 0%

Debates

1 session B

Avg quality: 0.67

Convergence

0.00 F 30 related hypothesis share this target

From Analysis:

epigenetic reprogramming aging neurons

Epigenetic reprogramming of aging neurons represents an active research focus within neurodegeneration, investigating whether reversible epigenetic modifications can restore youthful cellular states in post-mitotic neurons and potentially counteract age-related neuronal decline. This approach draws motivation from cellular reprogramming studies demonstrating that introduction of specific transcription factors can reset epigenetic age markers.

→ View full analysis & debate transcript

Hypotheses from Same Analysis (6)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic Axis and Dopaminergic Neuron Survival in Parkinson's Disease Models

Score: 0.790 | Target: SIRT1/NAD+ axis

Pharmacological EZH2 Inhibition Resets Polycomb-Mediated Repression of Synaptic Transmission Genes in 3xTg-AD Neurons

Score: 0.680 | Target: EZH2/H3K27me3

NeuroD1-Mediated Astrocyte Reprogramming Attenuates Neuroinflammation Through Epigenetic Remodeling of A1 Astrocyte Signature Genes

Score: 0.650 | Target: NeuroD1/NF-kB

Neuronal TET1 Upregulation Reactivates Immediate-Early Genes and Restores Dendritic Spine Plasticity via Active DNA Demethylation

Score: 0.640 | Target: TET1/5hmC

Transient OCT4/SOX2/KLF4/c-MYC Expression Reverses Epigenetic Age and Restores Visual Function in Aged Retinal Neurons

Score: 0.540 | Target: OCT4/SOX2/KLF4/c-MYC (OSKM)

Targeted DNA Demethylation at the Klotho Locus via dCas9-TET1 Rescues Neuroprotective Klotho Expression in Aging Neurons

Score: 0.510 | Target: KL (Klotho)/dCas9-TET1

→ View full analysis & all 7 hypotheses

Description

Differential susceptibility to partial reprogramming exists across neuronal subtypes—layer V pyramidal neurons show greater epigenetic age responsiveness than parvalbumin interneurons. AAV-PHP.eB-mediated delivery of three Yamanaka factors (OSK, excluding c-MYC to reduce proliferation risk) preferentially transduces cortical excitatory neurons, enabling therapeutic window for epigenetic clock reversal while minimizing off-target gliosis or DNA damage response activation. DEPRIORITIZED: shares H1's delivery limitations—AAV-PHP.eB tropism data for defined cortical subtypes is insufficient to support neuron-type specificity claims. Excluding c-MYC is not well-justified mechanistically for specific neuronal populations.

...

No AI visual card yet

3D Protein Structure (AlphaFold)

Open full viewer

AlphaFold predicted structure available for Q01860

View AlphaFold Structure

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.

5 citations 2 with PMID Validation: 0% 2 supporting / 3 opposing

✓ For (2)

No supporting evidence

No opposing evidence

(3) Against ✗

High Medium Low

Evidence Matrix — sortable by strength/year, click Abstract to expand

Evidence Types

MECH 1CLIN 1GENE 2EPID 1

Claim	Stance	Category	Source	Strength ↕	Year ↕	Quality ↕	PMIDs	Abstract
DNA methylation clocks established as biomarkers o…	Supporting	CLIN	-	-	-	-	PMID:29873779	-
AAV-mediated Yamanaka factor delivery reverses epi…	Supporting	GENE	-	-	-	-	PMID:37102749	-
AAV-PHP.eB tropism data for defined cortical subty…	Opposing	MECH	-	-	-	-	-	-
c-MYC exclusion not well-justified mechanistically…	Opposing	EPID	-	-	-	-	-	-
Epigenetic clock reversal at 353-CpG sites may be …	Opposing	GENE	-	-	-	-	-	-

Legacy Card View — expandable citation cards

✓ Supporting Evidence 2

DNA methylation clocks established as biomarkers of biological age

PMID:29873779

AAV-mediated Yamanaka factor delivery reverses epigenetic age in multiple mouse tissues

PMID:37102749

✗ Opposing Evidence 3

AAV-PHP.eB tropism data for defined cortical subtypes is insufficient to support neuron-type specificity claim…▼

AAV-PHP.eB tropism data for defined cortical subtypes is insufficient to support neuron-type specificity claims

c-MYC exclusion not well-justified mechanistically for specific neuronal populations

Epigenetic clock reversal at 353-CpG sites may be correlative rather than causative of functional rescue

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

Gap Analysis | 4 rounds | 2026-04-22 | View Analysis

🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼

Epigenetic Reprogramming of Aging Neurons: Therapeutic Hypotheses

Hypothesis 1: Partial Yamanaka Factor Reprogramming Reverses Epigenetic Age in Retinal Ganglion Cells

Title: Transient OCT4/SOX2/KLF4/c-MYC Expression Reverses Epigenetic Age and Restores Visual Function in Aged Retinal Neurons

Mechanism: Transient, partial reprogramming via short-term (48–72 hour) expression of four Yamanaka factors (OSKM) in post-mitotic retinal ganglion cells (RGCs) induces youthful DNA methylome and transcriptome patterns without driving full cell cycle re-entry or pluripotency. The brie

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼

Critical Evaluation of Epigenetic Reprogramming Hypotheses

Methodology Note

These hypotheses are evaluated against criteria for: (1) mechanistic specificity and plausibility, (2) quality and relevance of supporting evidence, (3) identifiability of confounds, (4) feasibility of falsification, and (5) translational validity.

Hypothesis 1: Partial Yamanaka Factor Reprogramming in RGCs

Weak Links

Mechanistic implausibility concerns:

The assertion that 48–72 hour OSKM expression avoids cell cycle re-entry in post-mitotic neurons overlooks well-documented OSKM-induced DNA

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼

Domain Expert Assessment: Epigenetic Reprogramming Hypotheses for Neurodegeneration

Executive Summary

Of the seven hypotheses evaluated, I recommend prioritizing four for detailed feasibility analysis. Hypotheses 1, 3, and 7 should be deprioritized based on mechanistic concerns that render them trial-unready within a 10-year horizon. Hypothesis 2 warrants conditional advancement pending age-context validation.